S100B and metastatic melanoma: In this retrospective study the prognostic performance of demographic data, clinical and histological prognostic markers and baseline serum LDH and S100B levels were tested in metastatic melanoma patients treated with anti-PD-1 using Cox regression and Kaplan-Meier survival analyses.